Bicycle Therapeutics plc Accumulated Other Comprehensive Income
Bicycle Therapeutics plc (BCYC) had Accumulated Other Comprehensive Income of -$5.42 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-07-30
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.42M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.28M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.50M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.47M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$5.42M 10-Q · filed 2026-07-30 |
| 2026-03-31 | -$5.28M 10-Q · filed 2026-04-30 |
| 2025-12-31 | -$3.50M 10-Q · filed 2026-07-30 |
| 2025-09-30 | -$3.47M 10-Q · filed 2025-10-30 |
| 2025-06-30 | -$3.36M 10-Q · filed 2025-08-08 |
| 2025-03-31 | -$1.46M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $119.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | -$3.19M 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$1.09M 10-Q · filed 2024-08-06 |
| 2024-03-31 | -$778.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$1.30M 10-K · filed 2025-02-25 |
| 2023-09-30 | $2.88M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$877.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $71.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $387.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $528.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$374.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$2.47M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$3.39M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$3.19M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$3.51M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$3.25M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$3.19M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$2.98M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$3.72M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$3.72M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$1.53M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$2.61M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$2.18M 10-Q · filed 2019-08-08 |
| 2018-12-31 | -$1.75M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |